Metabolic reprogramming of immune cells and metabolic intervention in cutaneous tumours
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Metabolic reprogramming of immune cells and metabolic intervention in cutaneous tumours
Artificial intelligence in oncology drug discovery: from target identification to therapeutic molecule generation
Combination treatment harnesses cellular recycling system to fight multiple myeloma
Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines
KRAS-targeting drugs show promise for rare appendix cancer
SPOP ‘double-donut’ structure closes the loop on unexplained cancer mutations
IU study finds obesity 'fuels' leukaemia, but a combo using popular weight-loss drugs may stop it
Genetic mapping identifies new hope for bone diseases
Novel microenvironment-targeted therapy for bone marrow recovery after injury
Cancer evolution study reveals biology of glioma progression
Breast cancer is rising fast in Asian American women
Insurance-supported integrative oncology programme improves patients’ symptoms